| Active ingredient (INN) | Nimodipine |
|---|
| Brand names | NIMOTOP nimodipine |
|---|
| Therapeutic category | Auto-created by Therapeutic Goods Administration — Medicine Shortages scraper |
|---|
| Controlled substance | No |
|---|
| Marketing-authorisation holders | Juno Pharmaceuticals Pty Ltd, Bayer Australia Ltd, Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., Camber Pharmaceuticals, Inc. |
|---|
| Registrations on file | 5 |
|---|
| Patient information leaflet (PIL) | Not on file |
|---|
| Summary of product characteristics (SPC) | Not on file |
|---|
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| Juno | 10 mg | — | 🇦🇺 AU | Juno Pharmaceuticals Pty Ltd | Active |
| NIMOTOP nimodipine | 30 mg | — | 🇦🇺 AU | Bayer Australia Ltd | Active |
| NIMOTOP nimodipine | 10mg | — | 🇦🇺 AU | Bayer Australia Ltd | Active |
| nimodipine | 30mg/1 | capsule | 🇺🇸 US | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | Active |
| Nimodipine | 60mg/20mL | solution | 🇺🇸 US | Camber Pharmaceuticals, Inc. | Active |